VULTAGGIO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.740
EU - Europa 6.476
AS - Asia 4.723
SA - Sud America 592
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 113
OC - Oceania 70
Totale 20.851
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.558
RU - Federazione Russa 1.995
IT - Italia 1.518
SG - Singapore 1.400
CN - Cina 1.185
PL - Polonia 1.138
HK - Hong Kong 620
VN - Vietnam 458
BR - Brasile 456
SE - Svezia 408
IE - Irlanda 374
KR - Corea 351
DE - Germania 231
FI - Finlandia 203
FR - Francia 185
BD - Bangladesh 153
IN - India 146
GB - Regno Unito 143
CA - Canada 98
JO - Giordania 93
UA - Ucraina 79
JP - Giappone 77
AU - Australia 67
AR - Argentina 56
TR - Turchia 56
ID - Indonesia 51
NL - Olanda 48
CH - Svizzera 35
ES - Italia 35
MX - Messico 32
NG - Nigeria 24
BE - Belgio 23
CI - Costa d'Avorio 21
IQ - Iraq 21
EC - Ecuador 20
VE - Venezuela 17
ZA - Sudafrica 17
PK - Pakistan 13
AE - Emirati Arabi Uniti 11
CO - Colombia 11
IL - Israele 11
MA - Marocco 11
UY - Uruguay 11
AT - Austria 10
LT - Lituania 10
PH - Filippine 10
CZ - Repubblica Ceca 9
TH - Thailandia 9
CL - Cile 8
EG - Egitto 8
JM - Giamaica 8
TN - Tunisia 8
UZ - Uzbekistan 8
HN - Honduras 7
SA - Arabia Saudita 7
MY - Malesia 6
PY - Paraguay 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
GT - Guatemala 5
NP - Nepal 5
BJ - Benin 4
GR - Grecia 4
OM - Oman 4
PA - Panama 4
PE - Perù 4
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
GE - Georgia 3
HU - Ungheria 3
KE - Kenya 3
LV - Lettonia 3
NI - Nicaragua 3
RO - Romania 3
SC - Seychelles 3
SN - Senegal 3
SV - El Salvador 3
TW - Taiwan 3
AL - Albania 2
HR - Croazia 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MQ - Martinica 2
NC - Nuova Caledonia 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
Totale 20.695
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.535
Ashburn 1.219
Warsaw 1.134
Singapore 983
Fairfield 584
Hong Kong 519
Chandler 445
San Jose 399
Dublin 373
Seoul 350
Milan 292
Hefei 263
Cambridge 241
Beijing 236
Seattle 232
Houston 227
Woodbridge 223
Wilmington 217
Council Bluffs 186
Florence 166
Los Angeles 149
Ann Arbor 144
Buffalo 142
Ho Chi Minh City 139
New York 122
Jacksonville 119
Lawrence 118
The Dalles 118
Altamura 116
Rome 114
Munich 111
Hanoi 110
Lauterbourg 107
Dallas 102
Princeton 96
Elk Grove Village 91
Moscow 89
Boardman 70
Boston 68
Helsinki 68
Shanghai 65
Mumbai 64
Melbourne 59
Kent 53
Tokyo 53
Paris 51
Medford 45
Turku 43
San Diego 42
São Paulo 40
Naples 39
Jakarta 37
Izmir 35
Figino 26
Frankfurt am Main 26
Lappeenranta 25
Toronto 25
Chicago 24
Dong Ket 24
London 24
Bologna 22
Luni 22
Palermo 22
Abidjan 21
Brooklyn 21
Abuja 20
Madrid 20
Norwalk 20
Brussels 19
Genoa 19
Orem 19
Chennai 18
Bari 17
Bern 17
Falls Church 17
Phoenix 17
Clifton 16
Guangzhou 16
Redondo Beach 16
Montreal 15
Tianjin 15
Washington 14
Zurich 14
Atlanta 13
Denver 13
Philadelphia 13
Salerno 13
Turin 13
Xi'an 13
Yubileyny 13
Biên Hòa 12
Haiphong 12
Johannesburg 12
Brasília 11
Da Nang 11
Hải Dương 11
Padua 11
Andover 10
Baghdad 10
Dhaka 10
Totale 13.435
Salva come PNG Salva come JPEG
Nome #
A novel allergen-adjuvant conjugate suitable for specific immunotherapy of respiratory allergy 388
Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation 364
Hapten-Specific TH17 Cells in the Peripheral Blood of β-Lactam-Induced AGEP. 326
Mepolizumab Reduces Inflammatory Eosinophils in Nasal Polyp Tissue and Restores Histological Alterations 317
Dermatophagoides pteronyssinus group 2 allergen bound to 8-OH modified adenine reduces the Th2-mediated airway inflammation without inducing a Th17 response and autoimmunity 302
The in vitro amplification of β-lactam-specific memory t cells improves the diagnostic performance of IGE detection and lymphocyte transformation test 288
Potential underestimation of risks in hazelnuts-allergic patients: a peculiar case report 270
Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study 265
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 258
T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis. 244
Efficacy and safety of mepolizumab (Anti-Interleukin-5) treatment in Gleich's syndrome 237
High proportion of inflammatory CD62Llow eosinophils in blood and nasal polyps of severe asthma patients 227
Biweekly hizentra® in primary immunodeficiency: A multicenter, observational cohort study (IBIS) 227
High serum β-lactams specific/total IgE ratio is associated with immediate reactions to β-lactams antibiotics 221
Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. 216
Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab 211
Miescher's cheilitis: Surgical management and long term outcome of an extremely severe case. 210
Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab 209
The TLR7 Ligand 9-Benzyl-2-Butoxy-8-Hydroxy Adenine Inhibits IL-17 Response by Eliciting IL-10 and IL-10-Inducing Cytokines. 207
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 206
A novel allergen-adjuvant conjugate suitable for allergen-specific Th2 redirection 206
Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction. 206
Urinary rituximab loss and rate of treatment failure in membranous nephropathy 205
The percentage of patients achieving complete remission of urticaria increases with repeated courses of treatment 205
Microchimerism and systemic sclerosis 204
Assays and strategies for immunogenicity assessment of biological agents. 201
Detection by flow cytometry of ESAT-6- and PPD-specific circulating CD4+ T lymphocytes as a diagnostic tool for tuberculosis. 196
Subcutaneous Immunoglobulin Replacement Therapy in Patients with Primary Immunodeficiency in Routine Clinical Practice: The VISPO Prospective Multicenter Study 195
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes 194
Asthma control in severe asthmatics under treatment with omalizumab: A cross-sectional observational study in Italy 193
Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42] 191
Drug-Specific Th2 Cells and IgE Antibodies in a Patient with Anaphylaxis to Rituximab 189
A novel nDer p2-conjugated TLR7 down-modulates Th2-associated lung inflammation by using a therapeutical protocol 187
Correlations Among Subcutaneous Immunoglobulin Dosage, Immunoglobulin G Serum Pre-infusional Levels and Body Mass Index in Primary Antibody Deficiency Patients: A Pooled Analysis from the SHIFT/IBIS Studies 186
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 184
Anti-infliximab IgE and non-IgE antibodies and induction of infusion-related severe anaphylactic reactions. 183
Omalizumab dampens type 2 inflammation in a group of long-term treated asthma patients and detaches IgE from FcεRI 182
Subcutaneous Immunoglobulin Twenty Percent Every Two Weeks in Pediatric Patients with Primary Immunodeficiencies: Subcohort Analysis of the IBIS Study 179
The anti-IgE monoclonal antibody omalizumab as adjuvant treatment in desensitization to carboplatin in patients with ovarian cancer 176
Can SSRI/SNRI antidepressants decrease the 'cytokine storm' in the course of COVID-19 pneumonia? 176
Redirection of allergen-specific Th2 responses by a modified adenine through Toll-like receptor 7 interaction and IL-12/IFN release 175
Seasonal Allergic Rhinitis Symptoms in Relation to COVID-19 174
Manifestations of Antidrug Antibodies Response: Hypersensitivity and Infusion Reactions. 172
Defective production of LIF, M-CSF and Th2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss. 169
A modified adenine chemically coupled to allergenic molecule(s) as inducer of allergen-specific Th2 cells redirection 169
EGPA Phenotyping: Not Only ANCA, but Also Eosinophils 168
Low-dose mepolizumab effectiveness in patients suffering from eosinophilic granulomatosis with polyangiitis 168
A modified adenines chemically coupled to allergen molecule of dermatophagoides pteronyssinus down-regulates allergen-specific Th2 cells responses 168
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study 168
A modified adenine chemically coupled to the allergen molecule of Dermatophagoides pteronyssinus redirects allergen-specific Th2 cells 167
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies 165
"Sarcoidosis-like" granulomatous disease in patients with common variable hypogammaglobulinemia 163
PS1-076. Redirection of allergen-specific TH2 cells by a modified adenine chemically coupled to allergenic molecule(s) 163
A modified adenine chemically coupled to allergen molecole redirects allergen-specific Th2 cells 162
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey 162
Apten-specific proliferation as diagnostic tool in drug hypersensitivity. 161
Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia. 161
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study 160
A novel antigen-conjugated TLR7 ligand regulates the lung inflammation and Th2-mediated response in a murine model of asthma 159
A modified adenine chemically coupled to allergen molecule(s) induce Interferon-gamma production and down regulate IL-4 and IL-5 in Th2 specific T cells 159
Long-term retention rate of mepolizumab treatment in severe asthma: a 36-months real-life experience 158
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 158
Primary antibody deficiencies represent an underestimated comorbidity in asthma patients: efficacy of immunoglobulin replacement therapy in asthma control 157
Association between "sarcoidosis-like" disease and common variable immunodeficiency (CVI): a new CVI variant showing an activation of the immune system. 155
Effectiveness of tocilizumab in hospitalized moderate-to-severe COVID-19 patients: a real-life study 154
Anti-RuvBL1/2 Autoantibodies Detection in a Patient with Overlap Systemic Sclerosis and Polymyositis 154
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 152
Baseline Eosinophil Count as a Potential Clinical Biomarker for Clinical Complexity in EGPA: A Real-Life Experience 151
Safety and tolerability of infliximab therapy: suggestions and criticisms based on wide clinical experience. 151
A modified adenines chemically coupled to allergenic molecule(s) as inducerof allergen-specific Th2 cells redirection 150
Persistence of both reversible airway obstruction and higher blood eosinophils may predict lung function decline in severe asthma 147
Effectiveness of low-dose intravenous immunoglobulin therapy in minor primary antibody deficiencies: a two-year real-life experience 146
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis 143
Modified adenine (9-benzyl-2-butoxy-8-hydroxyadenine) redirects Th2-mediated murine lung inflammation by triggering TLR7. 143
Total serum IgE levels influence the in vitro detection of ss-lactams-specific IgE antibodies 142
T cells specific for Candida albicans antigens and producing type 2 cytokines in lesional mucosa of untreated HIV-infected patients with pseudomembranous oropharyngeal candidiasis 142
Allergological in vitro and in vivo evaluation of patients with hypersensitivity reactions to infliximab. 140
Alert Card for Patients on Biologicals and Immunosuppressives: An EAACI Position Paper 139
Hydroxy-adenines as in vivo and in vitro immunomodulators of allergic responses 139
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 139
Modified adenines chemically coupled to allergen molecule induce interferon-gamma production and down-regulate IL-4 and IL-5 in Th2-specific T cells 136
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions 136
The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders 134
Adalimumab and anti-adalimumab antibodies a novel method of detection and quantification in human sera based on surface plasmon resonance technique 133
Coronary vasospasm during an acute allergic reaction 133
Poly(I:C) promotes the production of IL-17A by murine CD1d-driven invariant NKT cells in airway inflammation. 133
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study 132
Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature 131
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent 131
Short and long-term effect of a novel nDer p2-conjugated TLR7 ligand in the prevention of allergic lung inflammation 130
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 128
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 127
Multiorgan Infiltration by CD8+ T Cells and 1p;16p Translocation in a Patient with Hypogammaglobulinemia and a Reduced Number of B Cells. 126
Type 1 T helper cells specific for Candida albicans antigens in peripheral blood and vaginal mucosa of women with recurrent vaginal candidiasis. 126
Influence of total serum IgE levels on the in vitro detection of beta-lactams-specific IgE antibodies. 124
Lack of efficacy of Cyclosporine A in a patient with episodic angioedema and eosinophilia (Gleich's syndrome) 124
Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation 121
T-cell responses during allergen-specific immunotherapy. 121
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis 120
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type‐2 CRSwNP Over 48 Months 120
Totale 17.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.584
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.584
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022637 0 60 45 19 23 36 33 59 25 32 134 171
2022/20231.843 150 367 92 148 133 313 231 98 218 14 45 34
2023/2024873 36 71 106 60 80 110 59 166 17 54 71 43
2024/20255.295 187 546 310 856 1.390 557 102 357 266 144 257 323
2025/20267.880 874 968 689 641 856 274 868 336 525 522 375 952
2026/2027526 292 234 0 0 0 0 0 0 0 0 0 0
Totale 20.851